EXACT Therapeutics AS (DE:56F) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EXACT Therapeutics AS has decided not to proceed with its planned Subsequent Offering of new shares and warrants after successfully raising NOK 145 million through a Private Placement. The company’s shares have been trading at or below the subscription price, providing shareholders ample opportunity to mitigate dilution effects. This decision reflects the company’s strategic adjustment based on current market conditions.
For further insights into DE:56F stock, check out TipRanks’ Stock Analysis page.